Form 8-K - Current report:
SEC Accession No. 0001144204-17-063359
Filing Date
2017-12-12
Accepted
2017-12-12 17:00:40
Documents
6
Period of Report
2017-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv481140_8k.htm 8-K 27332
2 EXHIBIT 10.1 tv481140_ex10-1.htm EX-10.1 95451
3 EXHIBIT 10.2 tv481140_ex10-2.htm EX-10.2 141069
4 EXHIBIT 99.1 tv481140_ex99-1.htm EX-99.1 21574
5 GRAPHIC image_001.jpg GRAPHIC 10128
6 GRAPHIC image_002.jpg GRAPHIC 3290
  Complete submission text file 0001144204-17-063359.txt   305554
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 171252352
SIC: 2834 Pharmaceutical Preparations